Skip to content

Propolis Spray for the treatment of Oral Mucositis

Effecacy of Propolis Spray (Apis mellifera L) for the prevention and treatment of Oral Mucositis induced by Radiotherapy in patients with Head and Neck Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-673psmx
Enrollment
Unknown
Registered
2025-09-30
Start date
2025-05-12
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatitis

Interventions

This is an experimental study, called a randomized clinical trial, aimed at evaluating the efficacy of propolis spray in the treatment of radiotherapy-induced oral mucositis in patients with head and
patients undergoing radiotherapy with or without associated chemotherapy
patients over 18 years of age. Exclusion criteria: patients with metastasis
patients undergoing radiotherapy as palliative care
patients with allergies to propolis or any substance contained in the spray formula
patients unable to answer the questionnaires or in a serious condition that prevents them from participating in the study. Patient randomization will be simple, through a draw using opaque, sealed, an

Sponsors

Sociedade Pernambucana de Combate ao Câncer
Lead Sponsor
Sociedade Pernambucana de Combate ao Câncer
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with head and neck cancer; patients undergoing radiation therapy with or without associated chemotherapy; patients over 18 years of age, from both sexes

Exclusion criteria

Exclusion criteria: Patients with metastasis; latients undergoing radiotherapy as palliative care; patients with allergies to propolis or any substance contained in the spray formula; patients unable to complete the questionnaires or in a serious condition that prevents them from participating in the study

Design outcomes

Primary

MeasureTime frame
It is expected that the use of the propolis spray will reduce the incidence and severity of oral mucositis, significantly improving the quality of life of patients undergoing radiotherapy. In addition, lower hospitalization rates and reduced analgesic use are anticipated, leading to decreased healthcare costs. The use of a natural, affordable, and low-cost product may enhance treatment adherence. The expected impact includes fewer clinical and social complications associated with the disease. Thus, this study may contribute to effective, safe, and sustainable therapeutic alternatives.

Secondary

MeasureTime frame
No secondary outcomes are expected

Countries

Brazil

Contacts

Public ContactKatarina Pessôa

Universidade Federal de Pernambuco

katarina.haluli@ufpe.br+55(81)21268000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)